Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 December 2018 | Story Eugene Seegers | Photo IDEAS Lab
IBP read more
Learners enjoy a lesson delivered through an All-in-One device at an IBP-served school.

“Everyone is a genius. But if you judge a fish by its ability to climb a tree, it will live its whole life believing that it is stupid.” Eugene van Wyk, Project Coordinator of the Internet Broadcast Project (IBP) at the South Campus of the UFS, preaches a gospel along similar lines, a motto that belongs solely to the IBP: Taking quality education to where it matters.

Quality education accessible to all

Van Wyk believes that quality education should be accessible to all, especially as a tool to relieve poverty in disadvantaged communities. That is why he has made it his aim to extend the reach and exposure of the IBP. To that end, the IBP partnered with the Free State Department of Education (FSDoE) in presenting open days during August and September 2018 in each of the five Free State districts, emphasising innovation in education. At each of these days, the IBP presented their methods and successes, highlighting their use of innovation and technology in not only school education, but teacher development and upliftment as well.

Building on existing technology


The IBP lives up to its motto by building on existing technology, while thinking up new ways to use what is available. In addition, the IBP makes innovative use of emerging and new technologies. For instance, Van Wyk often quotes from a presentation by Ray Kurzweil, director of engineering at Google, author, and futurist, at the 2009 Handheld Learning conference: “Mobile phones are misnamed. They should be called gateways to human knowledge.” Therefore, plans are under way to develop a mobile app that will allow learners to download lesson content and even share it with learners who do not attend a Free State secondary school served by the IBP.

The value of the IBP can be seen in the tremendous upturn in matriculation success rates in the province, an impact that Van Wyk and the E-learning division at the FSDoE are keen to maintain and spread.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept